9tech score
/ 100

Lasa Supergenerics Limited (LASA) — Technical Setup

₹5.89 -5.00%   Strong Downtrend Normal Volatility Strong bearish

As of 2026-09-21 close Sector: Pharma Pharmaceuticals - Indian - Bulk Drugs & Formln

Summary

Lasa Supergenerics Limited is in a strong downtrend on the daily chart, with the weekly trend bearish and the monthly trend bearish. RSI(14) is 21.4, MACD is below its signal line, ADX reads 33 (trending). The stock trades 27.2% below its 200-day average and 58.2% below its 52-week high. Volume in the latest session was 0.6× its 20-day average. Over three months it has underperformed the Nifty 50 by 15.7 percentage points. Nearest resistance is ₹6.42. Its technical score is 9/100 (strong bearish).

Trend (daily)
Bearish
Trend (weekly)
Bearish
Trend (monthly)
Bearish
RSI (14)
21.36
MACD
Bearish
ADX (14)
33.09
Volume vs 20d avg
0.57×
Support
Resistance
₹6.42 (+9.0%)
RS vs Nifty (3M)
-15.66%
RS rating
6.00

🧮 How the 9/100 is built

Five components, 20 points each. Every rule is shown with the points it earned — the score describes the chart as it stands today; it is not a prediction.

Trend0/20
  • Close above 20-day EMA (-12.96)0/3
  • 20-day EMA above 50-day EMA0/3
  • 50-day EMA above 200-day EMA0/3
  • Close above 200-day SMA (-27.17)0/3
  • SuperTrend (10,3) pointing up0/3
  • ADX ≥ 20 with +DI above −DI (trend has strength) (33.09)0/3
  • Weekly trend up (above a rising 30-week average)0/2
Momentum0/20
  • RSI(14) in the bullish zone (55-70 best) (21.36)0/6
  • MACD line above its signal line0/4
  • MACD line above zero (-0.26)0/3
  • 12-day rate of change positive (-15.13)0/3
  • Stochastic %K above %D0/2
  • Outperforming the Nifty 50 over 3 months (-15.66)0/2
Volume0/20
  • On-balance volume rising over 20 sessions0/5
  • Chaikin Money Flow (20) positive (-0.24)0/5
  • More volume on up days than down days (20 sessions) (0.68)0/5
  • Close above 20-day VWAP (-14.64)0/5
Volatility4/20
  • Daily range (ATR%) contained — ≤2.5% scores full (6.76)0/6
  • Price in the upper half of its Bollinger Bands (-0.22)0/5
  • Shallow drawdown from the 52-week high (-58.17)0/5
  • Volatility contracting (20-day volatility below its 6-month median) (21.60)4/4
Support / Resistance5/20
  • Room to the next resistance (≥8% scores full) (9.00)5/5
  • Support close below (a tight, definable stop)0/5
  • Broke above a 20-day high in the last 5 sessions0/5
  • Within 5% of the 52-week high (-58.17)0/5

🧭 Regime: Strong Downtrend

Normal Volatility — Bollinger width is in the 75th percentile of the last six months.

Suits: Avoid longs / trend-following shorts. A strong downtrend: rallies are usually sold. Long setups need a completed reversal pattern first.

Classified from ADX, the 20/50-day EMA stack and price's distance from the 50-day average; volatility from band-width and ATR expansion.

Opens the AI Backtester with the SuperTrend (10,3) rules for LASA — supertrend (10,3) flips to an uptrend.

🕰️ Multi-timeframe

TimeframeTrendRSI (14)MACD hist.
Monthly▼ Bearish57.04-0.01
Weekly▼ Bearish34.42-0.06
Daily▼ Bearish21.36-0.09

Weekly: close vs a rising 30-week average (Weinstein). Monthly: close vs the 10-month average. Weekly SuperTrend: Bearish, weekly ADX 11.78.

📶 Volume & VWAP

Relative volume
0.57×
5d / 20d volume
0.77×
Volume ROC (10d)
-25.28%
Up/down volume
0.68×
OBV (20d)
Falling / flat
Chaikin MF (20)
-0.24
VWAP 20d
₹6.90 (-14.64%)
VWAP 50d
₹7.19 (-18.08%)
Anchored VWAP · 52W low
₹7.43 (-20.73%)
Anchored VWAP · 52W high
₹9.56 (-38.39%)
Anchored VWAP · YTD
₹8.50 (-30.71%)
Avg turnover (20d)
₹0.02 Cr

VWAPs are computed from daily bars (typical price × volume), not intraday ticks.

💪 Relative strength

vs Nifty 1M
-17.65%
vs Nifty 3M
-15.66%
vs Nifty 6M
-21.57%
vs Nifty 1Y
-39.21%
RS rating
6.00
Mansfield RS
-28.52
vs Pharma index 3M
-29.07%
vs sector peers 3M
-27.69%

LASA ÷ Nifty 50, rebased to 100 a year ago. Rising = outperforming.

🧱 Support & resistance

Clustered swing highs and lows from the last year; “touches” is how many swings formed the level.

LevelPriceDistanceTouches
Resistance₹7.62+29.5%4
Resistance₹7.12+20.8%2
Resistance₹6.71+13.9%2
Resistance₹6.42+9.0%1
Close₹5.89

52-week range: ₹5.67 – ₹14.08 (-58.17% from the high).

🌀 Fibonacci

Measuring the up-swing from ₹5.67 (2026-03-30) to ₹9.00 (2026-04-21). Price has retraced 93.4% of it.

RatioPriceDistance
23.6% retracement₹8.21+39.5%
38.2% retracement₹7.73+31.2%
50.0% retracement₹7.34+24.5%
61.8% retracement₹6.94+17.9%
78.6% retracement₹6.38+8.4%S/R confluence nearest
127.2% extension₹9.91+68.2%
161.8% extension₹11.06+87.7%
200.0% extension₹12.33+109.3%

🕯️ Candlesticks (last 5 sessions)

  • Doji 2026-09-08 neutral Weak · 35

Quality combines the pattern's reliability with its context: prior trend, volume, a support/resistance level and RSI.

↗️ Divergences

No regular divergence on RSI, MACD, OBV, MFI or Stochastic at the latest swings.

🏭 Pharma peers by technical score
Stock Close Chg Score Trend regimeRS rating (1-99)
BAFNAPHBafna Pharmaceuticals Limited ₹323.50 +1.99% 98 Strong Uptrend 98.00
AUROPHARMAAurobindo Pharma Limited ₹1,713 -1.19% 91 Uptrend 84.00
SUPRIYASupriya Lifescience Limited ₹957.70 +5.67% 91 Uptrend 82.00
KILITCHKilitch Drugs (India) Limited ₹201.02 +5.00% 89 Uptrend 70.00
LYKALABSLyka Labs Limited ₹85.00 +1.99% 87 Strong Uptrend 78.00
STARStrides Pharma Science Limited ₹1,235 +1.25% 87 Strong Uptrend 81.00
AKUMSAkums Drugs and Pharmaceuticals Limited ₹821.45 +4.82% 86 Strong Uptrend 93.00
LAURUSLABSLaurus Labs Limited ₹2,018 +3.25% 86 Strong Uptrend 96.00
ACUTAASAcutaas Chemicals Limited ₹3,426 -0.42% 85 Uptrend 93.00
JUBLPHARMAJubilant Pharmova Limited ₹1,049 -1.52% 84 Strong Uptrend 62.00
🔗 More on LASA

⚠️ Educational technical analysis computed automatically from end-of-day NSE prices — not investment advice. Flash Finance is not SEBI-registered. Indicators describe what price has done; they do not predict what it will do. Verify levels on a live chart and manage risk before acting.

⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI